Format
Sort by
Items per page

Send to

Choose Destination

Best matches for chloroquine coronavirus:

Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Colson P et al. Int J Antimicrob Agents. (2020)

[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]. multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia. et al. Zhonghua Jie He He Hu Xi Za Zhi. (2020)

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Wang M et al. Cell Res. (2020)

Search results

Items: 1 to 20 of 56

2.

Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.

Singh AK, Singh A, Shaikh A, Singh R, Misra A.

Diabetes Metab Syndr. 2020 Mar 26;14(3):241-246. doi: 10.1016/j.dsx.2020.03.011. [Epub ahead of print]

PMID:
32247211
3.

Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV.

Xie M, Chen Q.

Int J Infect Dis. 2020 Apr 1. pii: S1201-9712(20)30204-6. doi: 10.1016/j.ijid.2020.03.071. [Epub ahead of print] Review.

PMID:
32247050
4.

Potential therapeutic agents against COVID-19: What we know so far.

Lu CC, Chen MY, Chang YL.

J Chin Med Assoc. 2020 Apr 1. doi: 10.1097/JCMA.0000000000000318. [Epub ahead of print]

PMID:
32243270
5.

Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic.

Scuccimarri R, Sutton E, Fitzcharles MA.

J Rheumatol. 2020 Apr 2. pii: jrheum.200369. doi: 10.3899/jrheum.200369. [Epub ahead of print]

6.

The epidemiology, diagnosis and treatment of COVID-19.

Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y.

Int J Antimicrob Agents. 2020 Mar 28:105955. doi: 10.1016/j.ijantimicag.2020.105955. [Epub ahead of print]

PMID:
32234468
7.

Chloroquine in COVID-19: the evidence.

Gupta N, Agrawal S, Ish P.

Monaldi Arch Chest Dis. 2020 Mar 31;90(1). doi: 10.4081/monaldi.2020.1290.

8.

Emerging prophylaxis strategies against COVID-19.

Agrawal S, Goel AD, Gupta N.

Monaldi Arch Chest Dis. 2020 Mar 30;90(1). doi: 10.4081/monaldi.2020.1289. Review.

9.

Controversial treatments: an updated understanding of the Coronavirus Disease 2019.

Zhang C, Huang S, Zheng F, Dai Y.

J Med Virol. 2020 Mar 26. doi: 10.1002/jmv.25788. [Epub ahead of print] Review.

PMID:
32219882
10.

Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).

Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D, Gavazzi E, Maroldi R, Adamo M, Ammirati E, Sinagra G, Lombardi CM, Metra M.

JAMA Cardiol. 2020 Mar 27. doi: 10.1001/jamacardio.2020.1096. [Epub ahead of print]

PMID:
32219357
11.

Race to find COVID-19 treatments accelerates.

Kupferschmidt K, Cohen J.

Science. 2020 Mar 27;367(6485):1412-1413. doi: 10.1126/science.367.6485.1412. No abstract available.

PMID:
32217705
12.

Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy.

Dashraath P, Jing Lin Jeslyn W, Mei Xian Karen L, Li Min L, Sarah L, Biswas A, Arjandas Choolani M, Mattar C, Lin SL.

Am J Obstet Gynecol. 2020 Mar 23. pii: S0002-9378(20)30343-4. doi: 10.1016/j.ajog.2020.03.021. [Epub ahead of print]

PMID:
32217113
14.

The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 (COVID-19) and Its Research Progress in Forensic Toxicology.

Duan YJ, Liu Q, Zhao SQ, Huang F, Ren L, Liu L, Zhou YW.

Fa Yi Xue Za Zhi. 2020 Mar 25;36(2). doi: 10.12116/j.issn.1004-5619.2020.02.001. [Epub ahead of print] Review. English, Chinese.

15.

Could chloroquine /hydroxychloroquine be harmful in Coronavirus Disease 2019 (COVID-19) treatment?

Guastalegname M, Vallone A.

Clin Infect Dis. 2020 Mar 24. pii: ciaa321. doi: 10.1093/cid/ciaa321. [Epub ahead of print] No abstract available.

PMID:
32211771
16.

COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.

Zhou D, Dai SM, Tong Q.

J Antimicrob Chemother. 2020 Mar 20. pii: dkaa114. doi: 10.1093/jac/dkaa114. [Epub ahead of print]

PMID:
32196083
17.

Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.

Sahraei Z, Shabani M, Shokouhi S, Saffaei A.

Int J Antimicrob Agents. 2020 Mar 17:105945. doi: 10.1016/j.ijantimicag.2020.105945. [Epub ahead of print] No abstract available.

PMID:
32194152
18.

Audio Interview: New Research on Possible Treatments for Covid-19.

Rubin EJ, Baden LR, Morrissey S.

N Engl J Med. 2020 Mar 19;382(12):e30. doi: 10.1056/NEJMe2005759. No abstract available.

PMID:
32187489
19.

Teicoplanin: an alternative drug for the treatment of COVID-19?

Baron SA, Devaux C, Colson P, Raoult D, Rolain JM.

Int J Antimicrob Agents. 2020 Mar 13:105944. doi: 10.1016/j.ijantimicag.2020.105944. [Epub ahead of print]

20.

Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.

Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY, Ko WC, Hsueh PR.

J Microbiol Immunol Infect. 2020 Mar 4. pii: S1684-1182(20)30040-2. doi: 10.1016/j.jmii.2020.02.012. [Epub ahead of print] Review.

Supplemental Content

Loading ...
Support Center